Capricorn Scientific and ExcellGene Form Strategic Partnership to Support Biotech Industries
February 28, 2024 – Biotechnology – Capricorn Scientific, ExcellGene, biotechnology, partnership
- Capricorn Scientific GmbH and ExcellGene SA form a cooperation to support the biotechnology sector with their united expertise
- Through their combined capabilities, Capricorn Scientific and ExcellGene enhance processes, develop advanced products and provide effective solutions
- This customer-oriented approach is dedicated to accelerating the biotech journey from R&D up to clinical production.
28 February 2024 — Ebsdorfergrund, Germany — Capricorn Scientific GmbH and ExcellGene SA have established a strategic partnership within the biotechnology sector. Applying their collective expertise and capabilities, the collaboration seeks to help customers by optimising processes, developing products and offering solutions in biotechnology. Lastly, this partnership is dedicated to customer-oriented solutions and a commitment to excellence, with the aim of advancing biotech research, development and production.
Capricorn Scientific, a manufacturer of cell culture products based in Germany, specialises in producing media under good manufacturing practices (GMP) conditions, in both liquid and powder forms. They have built a global distribution network, enabling direct access and personalised customer relationships.
ExcellGene, a Swiss biotech company, specialises in cell line development, process optimisation and increasing expression rates for CHO and HEK recombinant production. Together with their expertise in media optimisation, ExcellGene brings valuable knowledge and capabilities in the cooperation. They have a long history of developing cutting-edge technologies and solutions for the biotech industry.
The collaboration between ExcellGene and Capricorn Scientific is characterised by a clear path of responsibilities and a mutually beneficial approach: While ExcellGene focuses on optimising cell clones and upstream processes, Capricorn Scientific specialises in production, commercial support and distribution of media, feeds and related products.
Their jointly developed upstream product for CHO cells, CHOventure, is especially for fed-batch processes and more than just a product. The strategy of CHOventure is highlighted by tailored support and direct communication for each project of customers. Leveraging the expertise of both companies and direct contact partners, they aim to expedite the transition from research to clinical phases. Maria & Florian Wurm from ExcellGene and Harry Brack from Capricorn Scientific expressed their commitment to fostering tomorrow’s breakthroughs and innovations together with their customers during their kick-off meeting.
Through the synergy of their complementary expertise and resources, ExcellGene and Capricorn Scientific aim to deliver enhanced solutions to customers in the biotechnology industry, thereby contributing to the advancement of research, development, and production processes.
About Capricorn Scientific
Founded in 2016, Capricorn has become a leading player in the biotech industry, dedicated to serving customers in the upstream sector. With a dynamic team of 72 coworkers, Capricorn is an ISO-certified German manufacturer of high-quality cell culture products. These solutions are tailored to meet the evolving needs of the entire biotech spectrum, from research and development to production. At Capricorn, the primary focus lies in providing innovative solutions for cell culture, including chemically defined media, feeding supplements, buffers and customisable products available in both powdered and liquid formats on GMP level. By offering a diverse range of products, they empower clients to enhance their processes and achieve superior results in their biotechnological endeavors. Driven by a passion for excellence and a commitment to advancing scale-up processes, Capricorn is proud to be a trusted partner for biotech professionals worldwide. Through dedication to quality, innovation and customer satisfaction, they continue to make significant contributions to the advancement of biotechnology, shaping the future of R&D and production. Visit: www.capricorn-scientific.com.
About ExcellGene
We are a Swiss biologics contract development and manufacturing organisation (CDMO) specialising in challenging protein expression services and based in Monthey, Switzerland. The heart of ExcellGene is applying smart science and technology to provide high quality proteins. We serve life science companies that need to move rapidly and confidently from concept and discovery to clinical use. ExcellGene is privately owned, was founded in 2001 by Prof Dr Florian M Wurm and is led by Dr Maria João Wurm, CEO since 2017. Visit: www.excellgene.com.
